Clinical Trial Update: Alemtuzumab and Rituximab in Aplastic Anemia [NA]

View source ↗

Summary

A clinical trial evaluating alemtuzumab and rituximab in aplastic anemia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Alemtuzumab (Alemtuzumab)
• Rituximab (rituximab)

Snippet

Sponsor: Hospital Universitario Dr. Jose E. Gonzalez | Conditions: Aplastic Anemia | NA | Status: WITHDRAWN